Nicolo' Schifano

Dr. Nicolo' Schifano

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
CCChristian Corsini
Christian Corsini
LBLuca Boeri
Luca Boeri
LCLuigi Candela
Luigi Candela
EPEdoardo Pozzi
Edoardo Pozzi
FBFederico Belladelli
Federico Belladelli
ASAndrea Salonia
Andrea Salonia
Corsini C, et al. World J Mens Health. 2022 Sep;40:e63. https://doi.org/10.5534/wjmh.220069

21 May 2022 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
NSNicolo' Schifano
Nicolo' Schifano
PCPaolo Capogrosso
Paolo Capogrosso
LBLuca Boeri
Luca Boeri
GFGiuseppe Fallara
Giuseppe Fallara
OCOmer Onur Cakir
Omer Onur Cakir
ASAndrea Salonia
Andrea Salonia

1 January 2021 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
NSNicolo' Schifano
Nicolo' Schifano
PCPaolo Capogrosso
Paolo Capogrosso
MTManuela Tutolo
Manuela Tutolo
FDFederico Deho
Federico Deho
FMFrancesco Montorsi
Francesco Montorsi
ASAndrea Salonia
Andrea Salonia
Schifano N, et al. World J Mens Health. 2020 Jan;38:e50. https://doi.org/10.5534/wjmh.200114

22 April 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Fabrizio SchifanoFabrizio Schifano
Fabrizio Schifano
SBStefania Bonaccorso
Stefania Bonaccorso
DADavide Arillotta
Davide Arillotta
Amira GuirguisAmira Guirguis
Amira Guirguis
John Martin CorkeryJohn Martin Corkery
John Martin Corkery
NSNicolo' Schifano
Nicolo' Schifano
Background: “Chemsex” involves the intake of a range of drugs (e.g., synthetic cathinones, gamma-hydroxybutyric acid/gamma-butyrolactone (GHB/GBL), ketamine, methamphetamine, “poppers”, type V phosphodiesterase (PDE) inhibitors, MDMA/ecstasy, cocaine, cannabis, and occasionally a few other molecules as well, to enhance and prolong sexual experiences. This paper aims to provide an overview of the clinical pharmacology of the vast range of drugs that are being used for chemsex with a focus on both the medical and psychopathological disturbances that they can produce. Methods: A narrative literature review was conducted using Pubmed, Scopus, and Web of Science databases. A total of 273 papers published up to January 2025 were screened; articles were selected based on relevance to chemsex/sexualized used behaviour and related substances. Both human and preclinical studies were considered. Results: The use of stimulants is likely related to the need to increase as much as possible both sexual arousal and performance but also to increase social interactions. Furthermore, the empathogenic/entactogenic activities of some MDMA-like “love drugs” facilitate the occurrence of “feeling closer/more intimate” emotional sensations, and GHB/GBL may provide the user with a subjective sensation of disinhibition, hence facilitating condomless meetings with a higher number of random partners. Conversely, ketamine may be used to both enjoy its psychotropic dissociative characteristics and facilitate the potentially painful receptive anal intercourse and/or fisting experiences. Most typically, these drugs are consumed in combination, with polydrug exposure possibly facilitating the occurrence of serotonergic syndrome, seizures, drug–drug pharmacokinetics’ interaction, and sympathomimetic overstimulation. Following these polydrug exposures, a range of psychopathological conditions have at times been reported. These issues may lead to misuse of opiates/opioids, gabapentinoids, and/or antipsychotics. Conclusions: Further actions should aim at reducing the stigma that prevents individuals from accessing necessary healthcare and support services. A multidisciplinary approach that combines medical, psychological, and social support remains key to managing the complex challenges posed by chemsex-related drug use.

1 July 2022 in Minerva Urology and Nephrology
Verified
Journal Article
Closed access
PCPaolo Capogrosso
Paolo Capogrosso
GFGiuseppe Fallara
Giuseppe Fallara
EPEdoardo Pozzi
Edoardo Pozzi
NSNicolo' Schifano
Nicolo' Schifano
LCLuigi Candela
Luigi Candela
FMFrancesco Montorsi
Francesco Montorsi
Article: Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center - Minerva Urology and Nephrology 2021 Apr 22 - Minerva Medica - Journals

11 October 2021 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
NSNicolo' Schifano
Nicolo' Schifano
FCFabio Castiglione
Fabio Castiglione
OCOnur Omer Cakir
Onur Omer Cakir
FMFrancesco Montorsi
Francesco Montorsi
GGGiulio Garaffa
Giulio Garaffa